Excellims Corp, founded in 2005, is a biotechnology company specializing in High-Performance Ion Mobility Spectrometry (HPIMS) and commercial research and development services. The company's core mission is to advance analytical capabilities in various industries, including pharmaceuticals, food and drug safety, clinical diagnostics, and chemical trace detection. Excellims offers a range of HPIMS-MS instruments such as the MC3100, MA3100, and GA2200, along with Vision Software to support their technology.
Notable affiliates include a dedicated management team and a network of investors who support the company's innovative endeavors. Excellims has achieved significant milestones in deploying HPIMS technology across multiple applications, enhancing the precision and efficiency of analytical processes. The company's impact is evident in its contributions to improving safety standards and research capabilities within its target markets.
